13F HOLDINGS REPORT
FCPM III SERVICES B.V.
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0000950123-25-002356
Total Value
$592.4M
Positions
12
Other Managers
3
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 5,943,205 | $152.7M | 25.78% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 4,653,976 | $119.6M | 20.19% |
| 3 | DYNE THERAPEUTICS INC | DYN | 4,036,476 | $95.1M | 16.05% |
| 4 | BICYCLE THERAPEUTICS PLC | BCYC | 3,452,330 | $48.3M | 8.16% |
| 5 | REPLIMUNE GROUP INC | REPL | 3,970,668 | $48.1M | 8.12% |
| 6 | ENGENE HOLDINGS INC | ENGNW | 6,738,362 | $44.8M | 7.56% |
| 7 | DYNE THERAPEUTICS INC | DYN | 1,426,370 | $33.6M | 5.67% |
| 8 | ASTRIA THERAPEUTICS INC | 04635X102 | 2,872,537 | $25.7M | 4.34% |
| 9 | ENGENE HOLDINGS INC | ENGNW | 2,894,199 | $19.2M | 3.25% |
| 10 | ACHILLES THERAPEUTICS PLC | 00449L102 | 2,390,050 | $2.7M | 0.46% |
| 11 | ENGENE HOLDINGS INC | ENGNW | 2,403,072 | $2.0M | 0.34% |
| 12 | ENGENE HOLDINGS INC | ENGNW | 475,076 | $400,632 | 0.07% |